Lexicon Pharmaceuticals, Inc. (LXRX): Weighted Average Diluted Shares
363.05M
Year ended 2025-12-31
+29.9%
3-year compound annual growth
+26.8%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 363.05M | +13.4% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | 320.03M | +44.7% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | 221.13M | +33.4% | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | 165.73M | +13.8% | 2025-03-07, From 2022-01-01 |
| 2021-12-31 | 145.65M | +31.4% | 2024-03-25, From 2021-01-01 |
| 2020-12-31 | 110.84M | -5.1% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | 116.75M | +10.3% | 2022-03-10, From 2019-01-01 |
| 2018-12-31 | 105.83M | +0.6% | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | 105.24M | n/a | 2020-03-12, From 2017-01-01 |